Pharmaceutical & Healthcare Services
Strategic Insight. Real-World Impact
I bring something most ADHD KOLs can't: clinical credibility, senior pharmaceutical industry experience, and direct access to an engaged patient community, all in one. Thirty years of working across HIV, rare disease, and biologics has taught me that the gap between efficacy and real-world outcomes is where the biggest opportunities lie.
Advisory Boards & Focus Groups
I facilitate patient insight panels and advisory boards, drawing on a network of over 150 neurodiverse global experts and experience facilitating across 130 countries. Additionally, I maintain a private parents community of 200+ members providing ongoing access to real-time insights that pharmaceutical teams rarely reach.
This isn't social media followers—it's an engaged, trust-based community where families share what they won't tell clinicians: real medication struggles, onboarding challenges, supply frustrations, and what actually drives their treatment decisions. I help teams hear the unfiltered patient voice.
Market Intelligence
Through my podcast (70K+ downloads, 122 countries), social platforms, and private parent community, I map treatment adherence pain points, emotional regulation versus concentration balance challenges, medication switching triggers and timing insights, and the real impact of supply chain disruptions on treatment persistence.
These multiple touchpoints provide comprehensive, real-time insights pharmaceutical teams rarely access directly—from both parents willing to speak publicly and those who share only in trusted, private spaces.
Medical Education & Speaking
Study days and presentations for clinicians across the UK, Europe, and the US, uniquely combining clinical evidence, neuroscience, and the unfiltered patient voice.
I bring what most medical education misses: real-world insights from families living with treatment decisions daily.
This isn't just academic theory, it's what works in practice, what fails, and why. Evidence-based content grounded in authentic patient experience.
Supply Chain & Access Strategy
I understand supply chain challenges from both sides: as Director of Supply Chain at AbbVie during the Humira crisis, the access to ARV in the Developing world, and as a mother sourcing ADHD medication during shortages. I help teams understand how supply decisions affect treatment persistence and patient outcomes on the ground.
Thought Leadership
LinkedIn positioning as a medical thought leader, with content bridging clinical evidence and lived experience. My podcast platform (70K+ downloads, 122 countries) features conversations with leading Neurodiverse experts, clinicians, and researchers, providing opportunities for partner messaging, expert placement, and access to engaged audiences actively seeking evidence-based information.
Why This Matters
This isn't just reach, it's trust, engagement, and the ability to gather real-world insights that pharmaceutical companies struggle to access.
70K+ podcast downloads across 122 countries show global relevance and sustained interest. 200+ active community members with constant daily engagement. 86% retention in paid community, exceptional in any digital health space, demonstrating genuine trust and engagement at scale.
These families share what they would never share with their child's clinician, without judgment, without concern about being seen as "bad parents," and without fear that honesty might affect their child's care. Real medication experiences during critical onboarding periods. Supply chain frustrations. The balance between benefits and challenges.
This provides real-time market intelligence about patient experiences, treatment barriers, and support needs. I bring these insights to pharmaceutical teams through advisory boards, focus groups, and patient insight panels, all conducted in accordance with ABPI guidelines for market research and medical education.